Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Ferroptocide is an inhibitor of thioredoxin (Trx) and a derivative of pleuromutilin (Item No. 19452).1 It inhibits Trx activity in ES-2 ovarian cancer cells when used at a concentration of 20 µM and is cytotoxic to ES-2 cells (IC50 = 1.6 µM). Ferroptocide (5 µM) induces ferroptosis in ES-2 cells, an effect that can be blocked by the iron chelator deferoxamine (DFO; Item No. 14595), antioxidant Trolox (Item No. 10011659), or ferroptosis inhibitor ferrostatin-1 (Item No. 17729). It decreases tumor volume in a 4T1 murine mammary carcinoma model using immunocompetent but not immunodeficient mice when administered at 50 mg/kg twice per week.
WARNING This product is not for human or veterinary use.
1. Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis. Nat. Chem. 11(6), 521-532 (2019).